British company acquires for Baltimore biotech

Published



Just 16 years ago two doctors sat at a crowded workbench in a free laboratory space injecting drug samples into tissue samples in test tubes.

Next month the doctors at In Vitro Technologies, leading a work force of 60 scientists and technicians, will become part of a large multinational drug testing empire, the London-based Celsis International PLC, to the tune of $35 million.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.